RecruitingAtrophic VaginitisVaginal AtrophyGenitourinary Syndrome of Menopause

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Eligible age

18+ yrs

Accepts

Women

Locations

9 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.

Sponsor: Stratpharma AG

You may qualify if…

✓ Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichen planus
✓ Continuous vulvovaginal symptoms
✓ Access to smartphone and tablet, laptop or computer
✓ Access to a valid email address

You may not qualify if…

✕ Unable to provide informed consent
✕ Patient unable to apply topical device
✕ Allergy or intolerance to ingredients or excipients of the formulation of studied products
✕ Systemic hormonal therapy started less than 30 days before baseline
✕ Systemic corticosteroids ongoing treatment or used within the last 30 days before baseline
✕ Ongoing topical HRT or corticosteroid treatment for the indication under investigation
✕ Topical HRT or corticosteroid treatment used for the indication under investigation within the last 30 days before baseline